HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 164 filers reported holding HEALTH CATALYST INC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,366,574 | +61.9% | 2,308,950 | +100.0% | 0.05% | -10.3% |
| Q2 2023 | $14,430,938 | +2.7% | 1,154,475 | -4.2% | 0.06% | -1.7% |
| Q1 2023 | $14,056,223 | +9.8% | 1,204,475 | 0.0% | 0.06% | +3.5% |
| Q4 2022 | $12,803,569 | +45.0% | 1,204,475 | +32.4% | 0.06% | +26.7% |
| Q3 2022 | $8,828,000 | -24.8% | 910,056 | +12.3% | 0.04% | -21.1% |
| Q2 2022 | $11,738,000 | +16.7% | 810,056 | +110.4% | 0.06% | +35.7% |
| Q1 2022 | $10,062,000 | -34.0% | 385,056 | 0.0% | 0.04% | -25.0% |
| Q4 2021 | $15,256,000 | -1.6% | 385,056 | +24.2% | 0.06% | -12.5% |
| Q3 2021 | $15,506,000 | +18.8% | 310,056 | +31.9% | 0.06% | +10.3% |
| Q2 2021 | $13,048,000 | +39.6% | 235,056 | +17.6% | 0.06% | +20.8% |
| Q1 2021 | $9,345,000 | +7.3% | 199,800 | -0.1% | 0.05% | -12.7% |
| Q4 2020 | $8,706,000 | +18.9% | 200,000 | 0.0% | 0.06% | -14.1% |
| Q3 2020 | $7,320,000 | – | 200,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 852,504 | $8,269,000 | 11.18% |
| Nepsis Inc. | 826,841 | $8,020,000 | 2.90% |
| First Light Asset Management, LLC | 1,149,833 | $11,153,000 | 1.13% |
| Bullseye Asset Management LLC | 55,434 | $538,000 | 0.31% |
| Portolan Capital Management | 303,602 | $2,945,000 | 0.31% |
| CVS HEALTH Corp | 32,273 | $313,000 | 0.30% |
| Rock Springs Capital Management LP | 880,000 | $8,536,000 | 0.22% |
| Granahan Investment Management | 648,299 | $6,289,000 | 0.20% |
| Bares Capital Management | 452,400 | $4,388,000 | 0.17% |
| Rhenman & Partners Asset Management AB | 180,000 | $1,588,000 | 0.17% |